Europe — EMA
Octreotide Pfizer Healthcare Ireland
Octreotide, the active ingredient in Octreotide Pfizer Healthcare Ireland, is a peptide synthetic analogue of somatostatin presented as a strength/form for injection use.
Request sourcing
What is Octreotide?
Octreotide, the active ingredient in Octreotide Pfizer Healthcare Ireland, is a peptide synthetic analogue of somatostatin presented as a strength/form for injection use. It regulates hormone secretion and is employed in the management of certain endocrine tumours and related conditions.
GNH USA supplies Octreotide Pfizer Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.
What is Octreotide used for?
Octreotide is a synthetic somatostatin analogue that modulates neuro‑endocrine pathways.
- Acromegaly: Reduces excess growth hormone secretion and improves clinical symptoms. - Carcinoid syndrome: Controls flushing and diarrhoea. - VIPoma-associated diarrhoea: - ... ... ...
